Medical professionals should think about no matter whether their individuals with underlying NAION threat elements may very well be adversely affected by utilization of PDE5 inhibitors. People who have now knowledgeable NAION are at elevated threat of NAION recurrence. Thus, PDE5 inhibitors, which include LEVITRA, must be utilized with caution in t